|Bid||0.00 x 900|
|Ask||26.59 x 1000|
|Day's Range||24.60 - 26.54|
|52 Week Range||21.34 - 43.75|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||35.11|
These companies are delivering strong results of late, and there's reason to be optimistic about what's coming next.
Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that it will report fourth quarter and full year ended December 31, 2020 operating results on Wednesday, March 24, 2021. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to review the Company's operating results and provide a general business update.
In this episode of Industry Focus: Wildcard, host Dylan Lewis is joined by Motley Fool contributor Brian Feroldi to look at the results of GoodRx (NASDAQ: GDRX), Inari (NASDAQ: NARI), and Amwell (NYSE: AMWL) and check if they are still interesting enough for your watch list. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.